Sunday, June 1, 2025

Latest

Organigram Signs Distribution Agreement With Shoppers

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) is working on strengthening its distribution lines. The company announced this morning that it will become Shoppers Drug Marts latest cannabis supplier for its online medical cannabis platform, which provides Canadians with access to a number of different medical cannabis producers.

The news, while not overly exciting given how many producers have now partnered with Shoppers Drug Mart for the distribution of medical product, is still a big development for Organigram. The company has seen a major shift within its sales mix as of the last quarter, with adult-use and medical product sales being on a significant downtrend. While the company beat market expectations handily, this was largely through an increase in international and wholesale product, which is typically sold at a lower margin.

The additional medical distribution line will as a result enable the firm to ideally capture growth in a segment that has been on the decline over a number of quarters. The medical category is typically one of the highest gross margin segments for licensed cannabis producers. However, given that Shoppers will be acting as a middle man in the equation, Organigram may see some price compression in the segment.

Under the signed agreement, Organigram is to supply Shoppers with dried flower, oil, and future derivative products for a period of three years. The agreement has an additional two year renewal option as well.

Organigram Holdings last traded at $3.14 on the Nasdaq.


Information for this briefing was found via Sedar and Organigram Holdings. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

Organigram Holdings: Numerous Analysts Cut Price Targets On Poor Earnings

Yesterday, Organigram Holdings (TSX: OGI) (NASDAQ: OGI) released its financial statements for the third quarter...

Wednesday, July 22, 2020, 04:58:34 PM

Organigram Sees Canaccord Raise Price Target To $3.25 After Earnings

On January 11th, Organigram Holdings (TSX: OGI) issued its second fiscal quarter of 2022. The...

Thursday, January 13, 2022, 03:48:00 PM

Organigram Announces $55 Million At-The-Market Offering

It appears at-the-market offerings have become all the rage in a cannabis sector desperately vying...

Wednesday, December 4, 2019, 10:05:30 AM

Week Ahead: Big Name Earnings To Dominate The Headlines

The upcoming week is going to be a busy one, as markets await first quarter...

Sunday, April 11, 2021, 05:30:00 PM

Organigram Conducts $60.1 Million Underwritten Financing

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) is the latest cannabis operator to raise funds. The...

Tuesday, November 10, 2020, 07:23:01 AM